Concord Medical Holdings, a leading radiotherapy center operator in China, raised the proposed price range for its upcoming IPO last Friday. The Beijing-based company is now expected to raise $126 million by offering 12 million American Depository Shares at a range of $9.50 to $11.50, up from its previously filed range of $9.00 to $11.00. At the mid-point of the revised range, Concord Medical will raise an additional 5% in proceeds. The company, which was founded in 2007 and booked $36 million in sales over the last 12 months, plans to list on the NYSE under the symbol CCM. Morgan Stanley, J.P. Morgan, and CICC are the lead underwriters on the deal, which is expected to price the week of Dec. 7.
